Skip to main content
Journal cover image

Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.

Publication ,  Journal Article
Wang, P; Liu, Z; Wu, C; Zhu, B; Wang, Y; Xu, H
Published in: Transplant Proc
October 2008

This study was designed to examine the role of monocyte-derived CD80 in providing costimulation to CD4+ cells, and to determine whether monocyte-derived CD80 expression is regulated by CD86/CD28 and CD40/CD154 pathways during allogeneic immunoresponses. Human endothelial cells (EC) and purified monocytes cocultured with or without CD4+ cells were analyzed by real-time quantitative polymerase chain reaction (RT-PCR) and florescence-activated cell scanning (FACS). Peripheral blood mononuclear cells (PBMC)-EC cocultures with or without costimulation blockade were analyzed by FACS. The effects of CD154 and CD28 blockade to inhibit lymphocyte proliferation were evaluated by mixed lymphocyte-EC reaction (MLER). RT-PCR demonstrated upregulation of CD80 transcripts in EC-stimulated monocytes in the absence of CD4+ cells. However, the surface expression of CD80 was undetectable. The expression of CD80 was restored in the presence of CD4+ cells. Additionally, CD80 blockade partially inhibited CD4+ cell proliferation induced by EC-conditioned monocytes. Monocytes demonstrated upregulation of CD80 on the surface during PBMC-EC interaction. CD86, CD28, and CD154 blockade did not prevent upregulation of monocyte-derived CD80 expression. CD28 and CD154 blockade partially inhibited lymphocyte proliferation of MLER. In summary, EC-stimulated monocytes upregulated CD80 expression at the transcript level but not on their surface in the absence of T cells. The surface expression of monocyte-derived CD80 is upregulated on EC-stimulated monocytes in the presence of T cells. CD154/CD40 and CD28/CD86 blockade cannot prevent monocyte-derived CD80 expression, suggesting that CD80 upregulation is through a CD154- or CD86-independent pathway. Specific therapy to prevent monocyte activation may be required for successful allograft transplantation.

Duke Scholars

Published In

Transplant Proc

DOI

ISSN

0041-1345

Publication Date

October 2008

Volume

40

Issue

8

Start / End Page

2729 / 2733

Location

United States

Related Subject Headings

  • Up-Regulation
  • Transcription, Genetic
  • Reverse Transcriptase Polymerase Chain Reaction
  • Monocytes
  • Lymphocyte Activation
  • Humans
  • Gene Expression Regulation
  • Endothelium, Vascular
  • CD40 Ligand
  • CD40 Antigens
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, P., Liu, Z., Wu, C., Zhu, B., Wang, Y., & Xu, H. (2008). Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium. Transplant Proc, 40(8), 2729–2733. https://doi.org/10.1016/j.transproceed.2008.07.076
Wang, P., Z. Liu, C. Wu, B. Zhu, Y. Wang, and H. Xu. “Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.Transplant Proc 40, no. 8 (October 2008): 2729–33. https://doi.org/10.1016/j.transproceed.2008.07.076.
Wang, P., et al. “Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.Transplant Proc, vol. 40, no. 8, Oct. 2008, pp. 2729–33. Pubmed, doi:10.1016/j.transproceed.2008.07.076.
Journal cover image

Published In

Transplant Proc

DOI

ISSN

0041-1345

Publication Date

October 2008

Volume

40

Issue

8

Start / End Page

2729 / 2733

Location

United States

Related Subject Headings

  • Up-Regulation
  • Transcription, Genetic
  • Reverse Transcriptase Polymerase Chain Reaction
  • Monocytes
  • Lymphocyte Activation
  • Humans
  • Gene Expression Regulation
  • Endothelium, Vascular
  • CD40 Ligand
  • CD40 Antigens